Biochemical aspects of PD-L1 regulation in cancer immunotherapy
PD-L1, frequently expressed in human cancers, engages with PD-1 on immune cells and
contributes to cancer immune evasion. As such, antibodies blocking the PD-1/PD-L1 …
contributes to cancer immune evasion. As such, antibodies blocking the PD-1/PD-L1 …
[HTML][HTML] Biochemical aspects of PD-L1 regulation in cancer immunotherapy
J Zhang, F Dang, J Ren, W Wei - Trends in biochemical sciences, 2018 - ncbi.nlm.nih.gov
PD-L1, frequently expressed in human cancers, engages with PD-1 on immune cells and
contributes to cancer immune evasion. As such, antibodies blocking the PD-1/PD-L1 …
contributes to cancer immune evasion. As such, antibodies blocking the PD-1/PD-L1 …
[引用][C] Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy
J Zhang, F Dang, J Ren, W Wei - Trends in Biochemical Sciences, 2018 - cir.nii.ac.jp
Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy.
J Zhang, F Dang, J Ren, W Wei - Trends in Biochemical Sciences, 2018 - europepmc.org
PD-L1, frequently expressed in human cancers, engages with PD-1 on immune cells and
contributes to cancer immune evasion. As such, antibodies blocking the PD-1/PD-L1 …
contributes to cancer immune evasion. As such, antibodies blocking the PD-1/PD-L1 …
Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy
J Zhang, F Dang, J Ren, W Wei - Trends in biochemical …, 2018 - pubmed.ncbi.nlm.nih.gov
PD-L1, frequently expressed in human cancers, engages with PD-1 on immune cells and
contributes to cancer immune evasion. As such, antibodies blocking the PD-1/PD-L1 …
contributes to cancer immune evasion. As such, antibodies blocking the PD-1/PD-L1 …
Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy
J Zhang, F Dang, J Ren, W Wei - Trends in Biochemical Sciences, 2018 - Elsevier
PD-L1, frequently expressed in human cancers, engages with PD-1 on immune cells and
contributes to cancer immune evasion. As such, antibodies blocking the PD-1/PD-L1 …
contributes to cancer immune evasion. As such, antibodies blocking the PD-1/PD-L1 …
Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy.
J Zhang, F Dang, J Ren, W Wei - Trends in Biochemical Sciences, 2018 - europepmc.org
PD-L1, frequently expressed in human cancers, engages with PD-1 on immune cells and
contributes to cancer immune evasion. As such, antibodies blocking the PD-1/PD-L1 …
contributes to cancer immune evasion. As such, antibodies blocking the PD-1/PD-L1 …